Institut für Labormedizin

Buchmueller LC, Wunderle C, Laager R, Bernasconi L, Neyer PJ, Tribolet P, Stanga Z, Mueller B, Schuetz P: Association of phenylalanine and tyrosine metabolism with mortality and response to nutritional support among patients at nutritional risk: a secondary analysis of the randomized clinical trial EFFORT. Front Nutr 2024, 11:1451081. IF 4

Bugarin C, Antolini L, Buracchi C, Matarraz S, Coliva TA, Van der Velden VH, Szczepanski T, Da Costa ES, Van der Sluijs A,Novakova M, Mejstrikova E, Nierkens S, De Mello FV, Fernandez P, Aanei C, Sedek L, Strocchio L, Masetti R, Sainati L, Philippe J, Valsecchi MG, Locatelli F, Van Dongen JJM, Biondi A, Orfao A, Gaipa G: Phenotypic profiling of CD34(+) cells by advanced flow cytometry improves diagnosis of juvenile myelomonocytic leukemia. Haematologica 2024, 109(2):521-532. IF 8.2

Collinson P, Hammerer-Lercher A, Aakre KM, Gruson D, Suvisaari J, Pulkki K, Stankovic S, Baum H, Lowry MT, Mills NL, Laitinen P: Implementation of high sensitivity troponin into routine clinical practice – results of the extended CARdiac MArkers guideline uptake in Europe group (CARMAGUE) survey. Clin Chim Acta 2024, 558:117900. IF 3.2

Dietze A, Neyer PJ, Speth MM, Metzler P, Elicin O, Balermpas P, Aebersold DM, Riesterer O, Stieb S: Therapy-Associated Saliva and Taste change Evaluation (TASTE) in head & neck cancer patients undergoing radiotherapy: a study protocol. BMC Cancer 2024, 24(1):865. IF 3.4

Glarner N, Puelacher C, Gualandro DM, Pargger M, Hure G, Maiorano S, Strebel I, Fried S, Bolliger D, Steiner LA, Lampart A, Lurati Buse G, Mujagic E, Lardinois D, Kindler C, Guerke L, Schaeren S, Mueller A, Clauss M, Buser A, Hammerer-Lercher A, Mueller C, Basel PMII: Association of preoperative beta-blocker use and cardiac complications after major noncardiac surgery: a prospective cohort study. Br J Anaesth 2024, 132(6):1194-1203. IF 9.1

Gruson D, Hammerer-Lercher A, Collinson P, Duff C, Baum H, Pulkki K, Suvisaari J, Stankovic S, Laitinen P, Bayes-Genis A: The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects. Crit Rev Clin Lab Sci 2024, 61(6):458-472. IF 6.6

Karbysheva S, Morovic P, Bellova P, Berger MS, Stiehler M, Meller S, Kirschbaum S, Lindenlaub P, Zgraggen A, Oberle M, Fuchs M, Perka C, Trampuz A, Conen A: Synovial fluid D-lactate – a pathogen-specific biomarker for septic arthritis: a prospective multicenter study. Clin Chem Lab Med 2024. IF 3.8

Kleer JS, Skattum L, Dubler D, Fischer I, Zgraggen A, Mundwiler E, Kim MJ, Trendelenburg M: Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report. Front Immunol 2023, 14:1257525. IF 5.7

Larsen EL, Nilius H, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Goetze JP, Bakchoul T, Nagler M: Accuracy of Diagnosing Heparin-Induced Thrombocytopenia. JAMA Netw Open 2024, 7(3):e243786. IF 10.5

Neyer PJ, Kabore B, Nakas CT, Diallo S, Tinto H, Post A, van der Ven AJ, Huber AR, Largiader CR, Hammerer-Lercher A: Increased erythroferrone levels in malarial anaemia. Br J Haematol 2024, 204(5):2066-2070. IF 5.1

Nilius H, Hamzeh-Cognasse H, Hastings J, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Bakchoul T, Cognasse F, Nagler M: Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia. Blood Adv 2024, 8(11):2825-2834. IF 7.4

Nilius H, Naas S, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Bakchoul T, Nakas C, Nagler M: The dynamic range of immunoassays for heparin-induced thrombocytopenia. J Thromb Haemost 2024. IF 5.5

Ritz J, Wunderle C, Stumpf F, Laager R, Tribolet P, Neyer P, Bernasconi L, Stanga Z, Mueller B, Schuetz P: Association of tryptophan pathway metabolites with mortality and effectiveness of nutritional support among patients at nutritional risk: secondary analysis of a randomized clinical trial. Front Nutr 2024, 11:1335242. IF 4

Staruch M, Speth MM, Neyer P, Riesterer O, Aebersold DM, Stieb S: Radiation-associated changes in saliva composition of head and neck cancer patients: A systematic review. Radiother Oncol 2024, 196:110279. IF 4.9

Stumpf F, Wunderle C, Ritz J, Bernasconi L, Neyer P, Tribolet P, Stanga Z, Mueller B, Bischoff SC, Schuetz P: Prognostic implications of the arginine metabolism in patients at nutritional risk: A secondary analysis of the randomized EFFORT trial. Clin Nutr 2024, 43(3):660-673. IF 6.6

Verbeek MWC, Rodriguez BS, Sedek L, Laqua A, Buracchi C, Buysse M, Reiterova M, Oliveira E, Morf D, Oude Alink SR, Barrena S, Kohlscheen S, Nierkens S, Hofmans M, Fernandez P, de Costa ES, Mejstrikova E, Szczepanski T, Slota L, Bruggemann M, Gaipa G, Grigore G, van Dongen JJM, Orfao A, van der Velden VHJ: Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study. Cytometry B Clin Cytom 2024, 106(4):252-263. IF 2.3

Wunderle C, Ciobanu C, Ritz J, Tribolet P, Neyer P, Bernasconi L, Stanga Z, Mueller B, Schuetz P: Association of leucine and other branched chain amino acids with clinical outcomes in malnourished inpatients: a secondary analysis of the randomized clinical trial EFFORT. Eur J Clin Nutr 2025, 79(1):42-49. IF 3.6

Wunderle C, Haller L, Laager R, Bernasconi L, Neyer P, Stumpf F, Tribolet P, Stanga Z, Mueller B, Schuetz P: The Association of the Essential Amino Acids Lysine, Methionine, and Threonine with Clinical Outcomes in Patients at Nutritional Risk: Secondary Analysis of a Randomized Clinical Trial. Nutrients 2024, 16(16). IF 4.8

Wunderle C, von Arx D, Mueller SC, Bernasconi L, Neyer P, Tribolet P, Stanga Z, Mueller B, Schuetz P: Association of Glutamine and Glutamate Metabolism with Mortality among Patients at Nutritional Risk-A Secondary Analysis of the Randomized Clinical Trial EFFORT. Nutrients 2024, 16(2). IF 4.8

Das Institut für Labormedizin legt besonderes Augenmerk auf angewandte Forschung. Neue Erkenntnisse und interessante Daten im Bereich der Labormedizin werden laufend publiziert. Zudem ist das Institut ein erfahrener Partner bei der Durchführung von klinischen Studien.

Publikationen 2024

Publikationen 2023

Publikationen 2022

Publikationen 2021

Publikationen 2020

Publikationen 2019

Publikationen 2018

Publikationen 2017

Publikationen 2016